SARM1 Antibody [H21M23]

Catalog No.: F8235

    Application: Reactivity:
    • Lane 1: SH-SY5Y, Lane 2: Neuro-2a, Lane 3: Mouse brain, Lane 4: Rat brain
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    使用情報

    Dilution
    1:1000
    1:30
    1:500
    1:50
    Application
    WB, IP, IHC, IF
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Rat, Human, Mouse
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    79 kDa 70 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。

    Datasheet & SDS

    生物学的記述

    Specificity
    SARM1 Antibody [H21M23] detects endogenous levels of total SARM1 protein.
    Clone
    H21M23
    Synonym(s)
    Kiaa0524, Sarm1, NAD(+) hydrolase SARM1, NADase SARM1, NADP(+) hydrolase SARM1, Sterile alpha and TIR motif-containing protein 1
    Background
    Sterile alpha and TIR motif–containing protein 1 (SARM1) is a multidomain adaptor and enzyme of the Toll/IL‑1 receptor (TIR) superfamily that functions as a central executioner of axon degeneration and as a regulatory component of innate immune signaling. The protein contains an N‑terminal region with HEAT/armadillo repeats that mediates autoinhibition and organelle association, tandem sterile alpha motif (SAM) domains that drive oligomerization into an octameric assembly, and a C‑terminal TIR domain that carries intrinsic NAD‑cleaving catalytic activity. This architecture allows SARM1 to act as a metabolic sensor in axons, where the ARM region binds nicotinamide adenine dinucleotide and maintains a closed, inactive conformation under basal conditions characterized by high NAD and low nicotinamide mononucleotide levels, while changes in the NMN:NAD ratio and upstream kinases such as MAPK modules promote conformational rearrangement and activation. Activation of SARM1 disrupts ARM‑mediated inhibition, permits SAM‑driven multimerization of the TIR domains, and unleashes robust NAD hydrolase and cyclase activity that converts NAD into nicotinamide, ADP‑ribose, and cyclic ADP‑ribose, triggering rapid depletion of axonal NAD, collapse of ATP production, ionic imbalance, and fragmentation characteristic of Wallerian and related forms of programmed axon degeneration. The SARM1 pathway thus integrates metabolic stress signals, such as loss of the axon survival factor NMNAT2 and associated drops in NAD, with rises in NMN, with structural rearrangements in the SARM1 complex, providing a direct molecular link between altered nucleotide metabolism and execution of axonal self‑destruction. SARM1 functions as a TIR‑domain adaptor in innate immunity where it participates in Toll‑like receptor signaling networks, acting as a negative regulator of TRIF‑dependent type I interferon and NF‑κB pathways and modulating production of pro‑inflammatory cytokines and interferon responses in selected cellular contexts. Expression in central nervous system neurons, glia, and immune cells connects SARM1 to neuroinflammatory environments, where its enzymatic and adaptor roles intersect and influence the balance between axon loss, tissue damage, and innate immune activation. Genetic, biochemical, and structural characterization places SARM1 at the core of an evolutionarily conserved NAD‑cleaving cell‑death axis, aligning its TIR‑domain NADase with plant and microbial TIR proteins involved in programmed cell death and host defense and establishing a mechanistic framework for targeting SARM1 in neurodegenerative diseases and axonopathies.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください